Mikulic M. Revenue of the worldwide pharmaceutical market from 2001 to 2023.: Statista; 2024 [Available from: https://www.statista.com/statistics/263102/pharmaceutical-market-worldwide-revenue-since-2001/]
da Fonseca EM. How can a policy foster local pharmaceutical production and still protect public health? Lessons from the health–industry complex in Brazil. Glob Public Health. 2018;13(4):489–502.
Morgan S, McMahon M, Greyson D. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia. Health Policy. 2008;87(2):133–45.
Kim IS, Milner VH. Multinational corporations and their influence through lobbying on Foreign Policy. Multinational corporations in a changing Global Economy. 2019;9(4):497–536.
Flynn M. Brazilian pharmaceutical diplomacy: social democratic principles versus soft power interests. Int J Health Serv. 2013;43(1):67–89.
Abbott FM. The WTO medicines decision: world pharmaceutical trade and the protection of public health. Am J Int Law. 2005;99(2):317–58.
Reichman JH. Compulsory licensing of Patented Pharmaceutical inventions: evaluating the options. J Law Med Ethics. 2009;37(2):247–63.
Article PubMed PubMed Central Google Scholar
Ogbodum MU, Shomuyiwa DO, Lucero-Prisno III, DE. African Medicines Agency: how it will change the landscape of medicines in Africa. Public Health Challenges. 2023;2(2):e96.
Ncube BM, Dube A, Ward K. Establishment of the African Medicines Agency: progress, challenges and regulatory readiness. J Pharm Policy Pract. 2021;14(1):29.
Article PubMed PubMed Central Google Scholar
UNIDO. Supporting Pharmaceutical production in Africa. Austria: United Nations Industrial Development Organization (UNIDO); 2015.
Fisher W, Okediji RL, Padmashree GS. Fostering production of Pharmaceutical products in developing countries. Mich J Int’l L. 2022;43(1):1–61.
Ouma-Mugabe J. Existential Priorities for the African Continental Free Trade Area. J, MFaA-M, editor: United Nations Economic Commission for Africa; 2022.
Gebre-Mariam T, Tahir K, Gebre-Amanuel S. Bringing industrial and health policies closer: reviving pharmaceutical production in Ethiopia. Making medicines in Africa: the political economy of industrializing for local health. 2016:65–84.
Mekonnen Z, Melaku T, Tucho GT, et al. The knock-on effects of COVID-19 pandemic on the supply and availability of generic medicines in Ethiopia: mixed methods study. BMC Health Serv Res. 2023;23(1):513.
Article PubMed PubMed Central Google Scholar
PMED. Context assessment and profile database development of the local pharmaceuticals, medical supplies and medical devices manufacturers in Ethiopia. Addis Ababa: Pharmacy and Medical Equipment Directorate (PMED), Ministry of Health, Government of Ethioipia.; 2020.
Marew T, Richmond FJ, Belete A, et al. Trends and challenges in access to essential medicines in Ethiopia and the contributions of local pharmaceutical production. Ethiop J Health Sci. 2022;32(5):1027–42.
Article PubMed PubMed Central Google Scholar
Gebremedhin Beedemariam GB, Efrem Nigussu EN, Gutu Tefera GT et al. Assessment of GMP compliance in water treatment systems of pharmaceutical industries in Ethiopia. 2015.
Alemayehu C, Mitchell G, Nikles J, et al. Views and perceptions about locally manufactured medicines in Ethiopia: a qualitative study of physicians, patients and regulatory authorities. BMC Health Serv Res. 2018;18:1–10.
Selam MN, Mengstu AT, Fentie AM, et al. Health professionals’ perceptions on local production and bioequivalence study of generic medicines: a cross-sectional survey of physicians and pharmacy professionals in Addis Ababa, Ethiopia. PLoS ONE. 2023;18(3):e0281665.
Article CAS PubMed PubMed Central Google Scholar
Cochran WG. Sampling techniques. New York: John Wiley and Sons, Inc.; 1963.
Lin N, Winn TB, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Archives Orofac Sci. 2006;1:9–14.
Nanjundeswaraswamy TS, Divakar S. Determination of sample size and sampling methods in applied research. Proc Eng Sci. 2021;3(1):25–32.
Mark S, Philip L, Adrian T. Research methods for Business Students. New Jersey: Prentice Hall; 2009.
Cheng Y, Johansen J, Hu H. Exploring the interaction between R&D and production in their globalisation. Int J Oper Prod Manage. 2015;35(5):782–816.
Lee M, Choi M. The determinants of research and development investment in the pharmaceutical industry: focus on financial structures. Osong Public Health Res Perspect. 2015;6(5):302–9.
Article PubMed PubMed Central Google Scholar
Vugigi S, Wanyanga W, Keter KF. Pharmaceutical partnerships for increased Access to Quality essential Medicines in the East Africa Region: final report. Nairobi: The Scinnovent Centre; 2020.
Vugigi SK, Thoithi GN, Ogaji JI, et al. Production capacity of the pharmaceutical manufacturing industry in Kenya. East Cent Afr J Pharm Sci. 2017;20(1–3):3–12.
Wong A, Hung KK, Mabhala M, et al. Filling the gaps in the pharmacy workforce in post-conflict areas: experience from four countries in Sub-saharan Africa. Int J Environ Res Public Health. 2021;18(15):8132.
Article PubMed PubMed Central Google Scholar
Bates I, John C, Bruno A, et al. An analysis of the global pharmacy workforce capacity. Hum Resour Health. 2016;14:1–7.
Karaki K, Ahairwe PE. Operationalising pharma manufacturing hubs in Africa: Policy options for the EU: ecdpm; 2022.p.
Ogada T. Building a competitive and socially inclusive local Pharmaceutical Manufacturing in West Africa through Enhancing Research, Innovation and Intellectual Property. African Center for Technology Studies; 2019.
ESS. key findings on the. 2022 Urban Bi-annual employment-unemployment survey: A comparative analysis of february 2022 and June 2022 with annual average. Addis Ababa: Ethiopian Statistics Service (ESS), Government of Ethiopia; 2022.
Schwab K, Samans R, Zahidi S, et al. The global gender gap report 2017: insight report. Geneva: World Economic Forum; 2017.
Christiansen L, Lin H, Pereira J, et al. Gender diversity in senior positions and firm performance: evidence from Europe. International Monetary Fund (IMF); 2016.
Obukohwo EO, Olele EH, Buzugbe PN. Assessing efficiency in the pharmaceutical sector of Nigeria. CBN J Appl Stat. 2018;9(2):131–48.
Adeyemi P, Olufemi O. The determinants of capacity utilization in the Nigerian manufacturing sector. J Econ Sustainable Dev. 2016;7(5):20–31.
UNDP. The role of Industry Parks in the local economy: the case of small and Medium Enterprises (SMEs) in Ethiopia. Addis Ababa: United Nations Development Programme (UNDP); 2024.
Chen X, Xue S, Lv M et al. Pharmaceutical industry in China: Policy, market and IP. Innovation, Economic Development, and Intellectual Property in India and China: Comparing Six Economic Sectors. 2019:215–250.
Sampath PG. Pharmaceutical manufacturing in Bangladesh–a success story: what can we learn. FEAPM Advocacy Ser. 2019(1).
Sindkhedkar M, Jagtap S, Shah C, et al. In:. Pharmaceutical research in India: current status and opportunities. Proc Indian Natl Sci Acad; 2020.
Paranhos J, Hasenclever L, Perin FS. The Brazilian Pharmaceutical Industry: actors, institutions, and policies. J Law Med Ethics. 2023;51(S1):126–35.
Tabikh M. Downtime cost and reduction analysis: Survey results. Mälardalen University; 2014.
Goel P, Aniruddha D, Mannan MS. Industrial alarm systems: challenges and opportunities. J Loss Prev Process Ind. 2017;50:23–36.
Ronoh W. Market Research to identify and analyze supply and demand gaps. COVID-19 Related Pharmaceutical Goods and Services in the COMESA Region: final validated report. Lusaka, Zambia. Common Market for Eastern and Southern Africa (COMESA); 2022.
EAC. EAC Regional Pharmaceutical Manufacturing Plan of Action 2017–2027. Arusha, Tanzania: East-African Community (EAC); 2018. 2.
UNCTAD. Improving the investment landscape for local production of essential antibiotics in Uganda: An Advisory Report. Geneva: United Nations Conference on Trade and Developmen (UNCTAD). 2023. Contract No.: UNCTAD/TCS/DIAE/INF/2023/7.
Steele P, Ali GKM, Levitskiy A et al. A case for Local Pharmaceutical Manufacturing in Africa in Light of the COVID-19 pandemic. Pamale Steele Associates 2020(1.1):1–14.
EFPIA. The Pharmaceutical Industry in Figures: Key Data for 2023. Brussels: European Federation of Pharmaceutical Industries and Associations (EFPIA); 2023 [Available from: https://efpia.eu/media/rm4kzdlx/the-pharmaceutical-industry-in-figures-2023.pdf
Chih-Yi S, Yao-Ning G, Kuang-Cheng C, et al. R&D Investments, Debt Capital, and Ownership Concentration: A Three-Way Interaction and lag effects on Firm Performance in China’s Pharmaceutical Industry. Front Public Health. 2021;9:708832.
Simpkin V, Namubiru-Mwaura E, Clarke L, et al. Investing in health R&D: where we are, what limits us, and how to make progress in Africa. BMJ Global Health. 2019;4(2):e001047.
Article PubMed PubMed Central Google Scholar
Panteli D, Edwards S. Ensuring access to medicines: how to stimulate innovation to meet patients’ needs? Copenhagen European Observatory on Health Systems and Policies; 2018 [Available from: https://www.ncbi.nlm.nih.gov/books/NBK526401/
Wei Y, Zhu J, Qiao J, et al. The impact of the consistency evaluation policy of generic drugs on R&D Investment Intensity of Pharmaceutical Companies—An empirical study based on the difference-in-differences model. Front Public Health. 2022;10:902025.
Article PubMed PubMed Central Google Scholar
UNIS. Science, technology and innovation.: UNESCO Institute for Statistics (UNIS). 2024 [Available from: http://data.uis.unesco.org/index.aspx?queryid=3685
WHO. Health researchers (in full-time equivalent) per million inhabitants, by income group, World Health Organization (WHO).: 2023 [Available from: https://www.who.int/observatories/global-observatory-on-health-research-and-development/indicators/health-researchers-in-full-time-equivalent-per-million-inhabitants-by-income-group-second-set-of-charts
Ezike TC, Okpala US, Onoja UL, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9(6):e17488.
Article CAS PubMed PubMed Central Google Scholar
Manipriyanka K, Naidu RK. Advances in drug Formulation Technology: enhancing bioavailability and patient compliance. J Adv Zool. 2023;44(S–5):2125–30.
Bashor CJ, Hilton IB, Bandukwala H, et al. Engineering the next generation of cell-based therapeutics. Nat Rev Drug Discov. 2022;21:655–75.
Article CAS PubMed PubMed Central Google Scholar
Danhof M, K K. The future of drug development: the paradigm shift towards systems therapeutics. Drug Discovery Today. 2018;23(12):1990–5.
Comments (0)